حمود عبدالكريم الموسى (@AlmousaHamoud) header
حمود عبدالكريم الموسى (@AlmousaHamoud) profile picture

‏‏‏‏‏‏‏‏‏‏‏‏‏إستشاري أمراض الحساسية و المناعة مستشفى الملك فيصل التخصصي و مركز الأبحاث Allergist and Immunologist King Faisal Specialist Hospital & Research cen

الرياض
Joined May 2018
Photo by حمود عبدالكريم الموسى (@AlmousaHamoud)Photo by حمود عبدالكريم الموسى (@AlmousaHamoud)Photo by حمود عبدالكريم الموسى (@AlmousaHamoud)Photo by حمود عبدالكريم الموسى (@AlmousaHamoud)Photo by حمود عبدالكريم الموسى (@AlmousaHamoud)Photo by حمود عبدالكريم الموسى (@AlmousaHamoud)Photo by حمود عبدالكريم الموسى (@AlmousaHamoud)Photo by حمود عبدالكريم الموسى (@AlmousaHamoud)Photo by حمود عبدالكريم الموسى (@AlmousaHamoud)Photo by حمود عبدالكريم الموسى (@AlmousaHamoud)
حمود عبدالكريم الموسى retweeted
1/ Excited to share our paper in @NEJM today, reporting that autoantibodies neutralizing type I IFNs (autoAb-IFN) underlie the fatal case of H7N7 avian flu in the Netherlands 23 years ago! #AvianFlu #BirdFlu nejm.org/doi/full/10.1056/NE…
3
17
4
106
7,720
حمود عبدالكريم الموسى retweeted
Ali, Alazami, and Al-Mousa describe a novel case of human BCL10 deficiency with a 13-year follow-up after hematopoietic stem cell transplantation. Their findings expand the clinical and genetic spectrum of this ultra-rare immunodeficiency hubs.la/Q04BMlQL0 #HSCT
1
5
3
322
Our results demonstrate excellent transplant outcomes, with an overall survival (OS) and event-free survival (EFS) of 91.5%, including an OS of 94.6% with matched related donors and 100% with matched unrelated donors.
1
1
144
حمود عبدالكريم الموسى retweeted
1/ We are excited to report in @PNASNews that autoantibodies neutralizing type I interferons underlie 35% of cases of Chikungunya virus (CHIKV) encephalitis or myelitis from a multiple cohort study. pnas.org/doi/10.1073/pnas.26…
5
22
4
123
10,024
حمود عبدالكريم الموسى retweeted
At #SIVF2026 — the Saudi Vaccine Awards 2026 honoring outstanding leaders and innovators in vaccination and public health. 🌍💉 Congratulations to all awardees for your remarkable contributions to advancing immunization and healthcare excellence.
3
1
407
حمود عبدالكريم الموسى retweeted
#5 Kanegane et al review unresolved issues in the pathogenesis of X-linked agammaglobulinemia (XLA), incl. non-coding BTK variants, contiguous deletion syndrome, Helicobacter infection, non-infectious neurodegeneration, renal involvement & malignancies: rupress.org/jhi/article/1/1/…
2
4
600
حمود عبدالكريم الموسى retweeted
#4 Type I IFN autoantibodies (auto-Abs) are associated w/ severe #COVID19. Peduti et al. reveal a 6.7% prevalence of auto-Abs in critically ill Brazilian patients, predominantly affecting older individuals: rupress.org/jhi/article/1/3/…
2
2
459
حمود عبدالكريم الموسى retweeted
#3 30-year @ESIDsociety registry analysis of 30,628 patients' longitudinal datasets show results of robust epidemiological studies on natural courses supporting newborn screening and future AI applications in IEI: rupress.org/jhi/article/1/3/…
2
5
415
حمود عبدالكريم الموسى retweeted
As 2025 wraps up, we're proud to celebrate the inaugural year of the Journal of Human Immunity (JHI)! 🎉Here are our 5 most-read articles so far 👇🧬
5
9
2
13
2,891
حمود عبدالكريم الموسى retweeted
Replying to @LangloisLab
@LangloisLab and I consider the potential impact of human inborn errors of immunity on the evolution of viruses, including the onset of viral pandemics: The potential impacts of human genetics on virus emergence | PNAS pnas.org/doi/10.1073/pnas.25…
2
18
1,787
حمود عبدالكريم الموسى retweeted
🔔 @jhumimmunity is delighted to share the abstracts from the 4th Congress of the Arab Society for Primary Immunodeficiencies #ARAPID, which took place April 24–26 in Casablanca. Explore the latest advancements in #PID clinical practice & research 👉 hubs.ly/Q03r1Z_k0
4
7
1,431
Thrilled to share our collaborative work in @Pediatric Rheumatology! We've proposed a definition for Monogenic Inflammatory Immune Dysregulation Disorders (MIIDDs). DOI: doi.org/10.1186/s12969-025-0…
2
4
1,011
قامت وزارة الصحة بمراجعة جدول التطعيم الوطني في عام 2019، حيث تم تأجيل إعطاء لقاح السل (BCG) من الولادة إلى عمر 6 أشهر، بهدف إتاحة الوقت لتشخيص أمراض نقص المناعة الأولية قبل التطعيم frontiersin.org/journals/imm…
3
1
1
977
في هذه الدراسة التي أجريناها انخفضت نسبة المضاعفات المرتبطة بلقاح BCG لدى الأطفال المصابون نقص المناعة الخلقي المركب الشديد بشكل ملحوظ بعد تعديل السياسة، من 46.1% إلى 2.6% مما يبرز أهمية تعديل جداول التطعيم لتتناسب مع طبيعة السكان و الأمراض المستهدفة
2
508
وتُعد سياسة التطعيم المعدلة في المملكة العربية السعودية نموذجًا يمكن الاستفادة منه لتحسين استراتيجيات التحصين في المناطق التي تنتشر فيها أمراض خلل المناعة الوراثية
353
Considering the high incidence of SCID in Saudi Arabia, the Ministry of Health revised its national vaccination schedule in 2019, postponing BCG administration from birth to 6 months of age to enable time for the diagnosis of primary immunodeficiency diseases before vaccination
2
1
522
The revised vaccination policy of Saudi Arabia provides a model for optimizing immunization strategies in regions with a high prevalence of inborn errors of immunity.
281